QIPAZI Trademark Information

Trademark by Syndax Limited

Pharmaceutical preparations for treatment of cancerous cells and tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immuno-suppressive cells; therapeutic agents for use in combination with cancer therapies such as immune checkpoint inhibitors, hormone therapies and chemotherapies

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: QIPAZI
Status/Status Date:
REGISTERED
9/3/2019
Serial Number: 88125137
Filing Date: 9/20/2018
Registration Number: 5848953
Registration Date: 9/3/2019
Goods and Services: Pharmaceutical preparations for treatment of cancerous cells and tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immuno-suppressive cells; therapeutic agents for use in combination with cancer therapies such as immune checkpoint inhibitors, hormone therapies and chemotherapies
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 6/18/2019
Last Applicant/Owner:
Syndax Limited
Marlow, Buckinghamshir SL71NT
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
COOLEY LLP
SUITE 700
1299 PENNSYLVANIA AVE., N.W.
WASHINGTON DC 20004-2004
Current Status:
REGISTERED
9/3/2019
Correspondent Search:
John Paul Oleksiuk is a correspondent of QIPAZI trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on